使,IBRUTINIBR-ICEDLBCL

Ni Zhu1, Rong-Bin Shen1, Jun-Fa Chen1

  • 1Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, 310006, Zhejiang, China.

概括

这项研究表明,机器学习模型可以准确预测治疗结果扩散大B细胞淋巴瘤 (DLBCL) 患者接受ibrutinib加R-ICE. 像LDH和CD5+表达这样的关键因素改善了生存预测.